327 related articles for article (PubMed ID: 24313462)
21. The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care.
Stein KR; Pearce DJ; Feldman SR
Semin Cutan Med Surg; 2005 Mar; 24(1):52-7. PubMed ID: 15900799
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of treatment modalities for psoriasis.
Tristani-Firouzi P; Krueger GG
Cutis; 1998 Feb; 61(2 Suppl):11-21. PubMed ID: 9787987
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
Alwawi EA; Krulig E; Gordon KB
Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
[TBL] [Abstract][Full Text] [Related]
24. Systemic and light therapies for the management of childhood psoriasis: part II.
Cordoro KM
Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714
[TBL] [Abstract][Full Text] [Related]
25. Safety considerations with combination therapies for psoriasis.
Nakamura M; Koo J
Expert Opin Drug Saf; 2020 Apr; 19(4):489-498. PubMed ID: 31985309
[No Abstract] [Full Text] [Related]
26. Treatment of psoriasis. Part 1. Topical therapy and phototherapy.
Lebwohl M; Ali S
J Am Acad Dermatol; 2001 Oct; 45(4):487-98; quiz 499-502. PubMed ID: 11568737
[TBL] [Abstract][Full Text] [Related]
27. Review of an established UK home phototherapy service 1998-2011: improving access to a cost-effective treatment for chronic skin disease.
Cameron H; Yule S; Dawe RS; Ibbotson SH; Moseley H; Ferguson J
Public Health; 2014 Apr; 128(4):317-24. PubMed ID: 24726005
[TBL] [Abstract][Full Text] [Related]
28. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
Tzu J; Kerdel F
Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
[TBL] [Abstract][Full Text] [Related]
29. [Prescription of phototherapy in psoriasis].
Beani JC
Rev Prat; 2004 Jan; 54(1):43-7. PubMed ID: 15049599
[TBL] [Abstract][Full Text] [Related]
30. Management of psoriasis.
Al-Kudwah AJ; Feldman SR
South Med J; 2009 Jun; 102(6):631-6. PubMed ID: 19434023
[TBL] [Abstract][Full Text] [Related]
31. Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
Raposo I; Torres T
Am J Clin Dermatol; 2016 Aug; 17(4):349-58. PubMed ID: 27113059
[TBL] [Abstract][Full Text] [Related]
32. Care of patients with psoriasis: an audit of U.K. services in secondary care.
Eedy DJ; Griffiths CE; Chalmers RJ; Ormerod AD; Smith CH; Barker JN; Potter J; Ingham J; Lowe D; Burge S
Br J Dermatol; 2009 Mar; 160(3):557-64. PubMed ID: 19120330
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010.
Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y
J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814
[TBL] [Abstract][Full Text] [Related]
34. Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability.
Farahnik B; Patel V; Beroukhim K; Zhu TH; Abrouk M; Nakamura M; Singh R; Lee K; Bhutani T; Koo J
Psoriasis (Auckl); 2016; 6():105-111. PubMed ID: 29387597
[TBL] [Abstract][Full Text] [Related]
35. [Psoriasis in the era of biologics].
Torres T; Velho GC; Sanches M; Selores M
Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
[TBL] [Abstract][Full Text] [Related]
36. Phototherapy in the age of biologics.
Walker D; Jacobe H
Semin Cutan Med Surg; 2011 Dec; 30(4):190-8. PubMed ID: 22123416
[TBL] [Abstract][Full Text] [Related]
37. Racial Differences in Perceptions of Psoriasis Therapies: Implications for Racial Disparities in Psoriasis Treatment.
Takeshita J; Eriksen WT; Raziano VT; Bocage C; Hur L; Shah RV; Gelfand JM; Barg FK
J Invest Dermatol; 2019 Aug; 139(8):1672-1679.e1. PubMed ID: 30738054
[TBL] [Abstract][Full Text] [Related]
38. Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use.
Takeshita J; Gelfand JM; Li P; Pinto L; Yu X; Rao P; Viswanathan HN; Doshi JA
J Invest Dermatol; 2015 Dec; 135(12):2955-2963. PubMed ID: 26214380
[TBL] [Abstract][Full Text] [Related]
39. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review.
Florek AG; Wang CJ; Armstrong AW
Arch Dermatol Res; 2018 May; 310(4):271-319. PubMed ID: 29442137
[TBL] [Abstract][Full Text] [Related]
40. Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis.
Scheinfeld N
J Dermatolog Treat; 2007; 18(4):197-208. PubMed ID: 17671880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
